Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Characterization of H-box region mutants of WalK inert to the action of waldiomycin in Bacillus subtilis.

Kato A, Ueda S, Oshima T, Inukai Y, Okajima T, Igarashi M, Eguchi Y, Utsumi R.

J Gen Appl Microbiol. 2017 Sep 5;63(4):212-221. doi: 10.2323/jgam.2016.10.007. Epub 2017 Jul 1.

2.

Angucycline antibiotic waldiomycin recognizes common structural motif conserved in bacterial histidine kinases.

Eguchi Y, Okajima T, Tochio N, Inukai Y, Shimizu R, Ueda S, Shinya S, Kigawa T, Fukamizo T, Igarashi M, Utsumi R.

J Antibiot (Tokyo). 2017 Mar;70(3):251-258. doi: 10.1038/ja.2016.151. Epub 2016 Dec 21.

PMID:
27999439
3.

Study on in vivo effects of bacterial histidine kinase inhibitor, Waldiomycin, in Bacillus subtilis and Staphylococcus aureus.

Fakhruzzaman M, Inukai Y, Yanagida Y, Kino H, Igarashi M, Eguchi Y, Utsumi R.

J Gen Appl Microbiol. 2015;61(5):177-84. doi: 10.2323/jgam.61.177.

4.

Waldiomycin, a novel WalK-histidine kinase inhibitor from Streptomyces sp. MK844-mF10.

Igarashi M, Watanabe T, Hashida T, Umekita M, Hatano M, Yanagida Y, Kino H, Kimura T, Kinoshita N, Inoue K, Sawa R, Nishimura Y, Utsumi R, Nomoto A.

J Antibiot (Tokyo). 2013 Aug;66(8):459-64. doi: 10.1038/ja.2013.33. Epub 2013 May 1.

PMID:
23632918

Supplemental Content

Loading ...
Support Center